Exclusively to BridgeMaster Medical

Thursday, May 17th, 2012

Bridgemaster medical is the only company that offers flexible purchasing options on:

4201-ZAC: The Complete Fetal Scalp Blood Sampling Kit with a Self Illuminating Amnioscope
BridgeMaster Medical’s aim is to bring pioneering ideas to reality by designing and manufacturing medical devices that provide a genuine benefit to the end user. In this instance we have listened to our customer’s needs and issues surrounding a strong clinical practice in Fetal Scalp Blood Sampling (FSBS).

Our Blood Sampling Kit is now available with totally flexible purchasing options such as:
• The Complete Fetal Scalp Blood Sampling Kit (4201-AC)
• Electronically Illuminated Amnioscope in 28mm (ELA01) and 24mm (ELA02)
• The Complete Fetal Scalp Blood Sampling Kit with a standard 28mm ELA01 (4201-ZAC01)
• The Complete Fetal Scalp Blood Sampling Kit with a smaller 18mm ELA02 (4201-ZAC02)

The Complete Fetal Scalp Blood Sampling Kit and ELA devices are supplied in separate boxes, so there are even more options for you to purchase as many of each as you like in the same order. eg. 5 units of 4201-ZAC01 and 10 units of 4201-ZAC02.

Please note when purchasing these items if you wanted to buy both the Kit and ELA together it is significantly less expensive to buy them under the above codes.

With these options available you can still take advantage of the bulk & standing order prices where even more discounts are available.

Prices and samples are available at your request so please feel free to contact us on: 01235 858290 or by email: info@bmmedical.co.uk for further details.

We look forward to hearing from you.

The ebb™ Roadshow comes to Europe

Sunday, May 6th, 2012

BridgeMaster and Glenveigh Medical took the road for the last two weeks of April
and supported four Post Partum Haemorrhage clinical seminars in as many countries.
PPH is a serious emergency and while tamponade is not a new technique, using uterine
balloons to control post-partum bleeding has started to gain more popularity.

The first seminar in Dublin, Ireland, was sponsored by O’Leary Medical and was well
attended by close to 40 doctors and midwives. The keynote was given by Glenveigh’s
founder and clinical director David Adair and followed with perspectives on PPH
management in Ireland by Dr. Bridgette Byrne and Professor Michael Turner of the
Coombe University Hospital.

L to R: Dr. David Adair, Dr. Bridgette Byrne, Professor Michael Turner in Dublin

Seminar in Dublin

Valerie Cole from OLM with Dr Byrne and Professor Turner

Next was Lille, France, at an event organised by Dr. Patrick Rozenberg from
Poissy with Professor Philippe Deruelle of Lille. Following Dr. Adair’s presentation,
Dr. Thomas Popowski presented an update on his research and a lively discussion
with an audience of some 35 clinicians ensued. Current clinical practice in France is
centred on uterotonics in the first stages, but there is growing interest in tamponade
as an adjunct therapy.

In Finland, and as part of Steripolar’s bi-annual clinical
seminar on Obstetrics, Glenveigh sponsored a talk on PPH management by Dr.
Kimberley DeStefano, Medical Director for Maternal Fetal Medicine at St.
David’s North Austin Medical Center in Texas. Dr. DeStefano described her
clinical protocols for managing PPH and the important role of ebb in her
clinical practice. In Estonia, Dr. DeStefano presented to a small group of
obstetricians at the Tallinn women’s centre and a discussion and hands-on
session with ebb™ followed. In both cases it was interesting to hear
discussions regarding the similarities in the protocols for managing severe PPH
and the level of interest in using ebb™ to help reduce blood loss and
transfusions.

Dr. Kim DeStefano with Riitta Dahlström from Steripolar

Finland's seminar

We’d like to thank Dr. David Adair and Dr. Kim DeStefano for

their support, as well as a special thanks to our partners for helping organise
our trips and for hosting our events. We’d like to especially recognise Valerie
Cole and Aisling Healy at OLM, Riitta Dahlström, Anu Parviainen and Kati
Granlund at Steripolar, and Mart Seer at Sonotrade.

May 2012 News

Tuesday, May 1st, 2012

Patents received:

BridgeMaster medical are pleased to announce that along with our patent for the People’s
Republic of China we have now been granted one in the US. These primarily
relate to ELA and Genie, which is an integral part of all of our current
product range.

This was issued on 4^th March 2012 under patent number: D657057 and if you
would like a copy of the patent certificate please ask and we would be happy to
forward one to you.

This patent grant will help us to now look for additional distribution in the United States
of America, subject to FDA approval.

New Product Developments

With the issue of the patents solved we now have several new products under development
and introductions should be made over the next 12 months or so.

Customer Satisfaction results:

We value all of our customer opinions and will continue to provide the most effective
service we can.

The response to the Customer Satisfaction Survey provides us with information to allow us to
help you the best we can. Thank you to those who took the time to complete this
survey.

Following the allocation of the results we have  put
together the following aims in order to  improve customer service for you, our
customers:

Aim 1: Improve knowledge levels of staff members to ensure
efficient customer service is provided.

We will do this by:

Ensuring staff have knowledge of product information/prices.

And that they are informed of any changes in the company

Aim 2: Take steps to make the size of the packaging more
appropriate to the size of the goods

We have already:

Adjusted both the box sizes and ensure that all empty space
is filled with polystyrene chips and that the goods are held firmly in the
packaging.

Aim 3: Make sure all Distributors are aware of the returns
procedure

We will send out the returns procedure on an annual basis to make sure all
Distributors are aware of how to deal with returns. This procedure was sent out
on 4^th April 2012 to all Distributors please let us know if you
require

What is BridgeMaster medical up to in 2012?

Tuesday, March 20th, 2012

Please find below BridgeMaster medical’s plans for 2012:

Introducing ebb™ – The Complete Tamponade System

Monday, March 12th, 2012

ebb™ – The only tamponade system that has dual balloons to control both vaginal and uterine bleeding

Postpartum haemorrhage is a serious emergency and is the most common cause of maternal death. Without treatment postpartum haemorrhage can cause death within two hours in a healthy woman. Treatment with uterotonics works in many cases, but when uterotonics fail, continued blood loss may lead to a potentially life-threatening situation.

Tamponade may be the only therapeutic measure needed to stop postpartum hemorrhage. Within minutes, tamponade treatment predicts if the bleeding is likely to stop or requires surgery. An early decision to use tamponade may reduce blood loss and the need for transfusion.

ebb™ provides a complete tamponade solution to the emergency of postpartum haemorrhage and was designed by world-renowned maternal-fetal medicine specialists Michael A. Belfort and Gary A. Dildy.

The balloon is made of malleable yet extremely strong polyurethane, allowing ebb™ to expand and conform to any uterine shape. ebb™ also features a vaginal balloon to control vaginal bleeding and act as an anchor to support the uterine balloon. External ports allow independent control of inflation, deflation, irrigation, and drainage.

References: 1. World Health Organization. Risking death to give life. Available at: http://www.who.int/whr/2005/chapter4/en/index1.html

2. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol. 1991;77:69-76.

3. Combs CA, Murphy EL, Laros RK Jr. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol. 1991;77:77-82.

4. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003;101:767-772.

5. Keriakos R, Mukhopadhyay A. The use of the Rusch balloon for management of severe postpartum haemorrhage. J Obstet Gynaecol. 2006;26:335-338.